4//SEC Filing
Nash Huw M. 4
Accession 0001209191-23-057403
CIK 0001623526other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:17 PM ET
Size
8.4 KB
Accession
0001209191-23-057403
Insider Transaction Report
Form 4
Nash Huw M.
COO & CBO
Transactions
- Award
Restricted Stock Unit (RSU)
2023-12-01+8,463→ 8,463 totalExp: 2025-12-01→ Common Stock (8,463 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2023-12-01−65,600→ 0 totalExercise: $60.00Exp: 2031-03-01→ Common Stock (65,600 underlying)
Footnotes (4)
- [F1]The canceled option vested as to 1/48th of the total award on April 2, 2021 and provided for 1/48th of the total award to vest monthly thereafter, subject to the reporting person's continued service to the Issuer through each vesting date.
- [F2]On December 1, 2023, the Issuer cancelled, pursuant to the Issuer's option exchange program, options to purchase 65,600 shares of Common Stock of the Issuer and in exchange issued to the reporting person 8,463 restricted stock units.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
- [F4]7,053 restricted stock units will vest on December 1, 2024 and 1,410 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001780085
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:17 PM ET
- Size
- 8.4 KB